β¨ Medicines Notices
7 APRIL 2011 NEW ZEALAND GAZETTE, No. 47
Product: Litorstat
Active Ingredient: Atorvastatin calcium 41.439mg equivalent to atorvastatin 40mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India
Product: Litorstat
Active Ingredient: Atorvastatin calcium 82.879mg equivalent to atorvastatin 80mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Mylan New Zealand Limited
Manufacturer: Matrix Laboratories Limited, Nashik, India
Product: Losartan Potassium
Active Ingredient: Losartan potassium 100mg
Dosage Form: Tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Losartan Potassium
Active Ingredient: Losartan potassium 25mg
Dosage Form: Tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Losartan Potassium
Active Ingredient: Losartan potassium 50mg
Dosage Form: Tablet
New Zealand Sponsor: Ipca Pharma (NZ) Pty Limited
Manufacturer: Ipca Laboratories Limited, Dadra and Nagar Haveli, India
Product: Luveris
Active Ingredient: Lutropin alfa, rch 75IU
Dosage Form: Powder for injection
New Zealand Sponsor: Pharmacy Retailing (NZ) Limited t/a Healthcare Logistics
Manufacturer: Merck Serono SA, Aubonne, Switzerland
Product: Parafast EXTRA (General Sale)
Active Ingredients: Caffeine 65mg
Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Medreich Limited, Bangalore, India
Product: Parafast EXTRA (Pharmacy Only)
Active Ingredients: Caffeine 65mg
Paracetamol 500mg
Dosage Form: Tablet
New Zealand Sponsor: Arrow Pharmaceuticals (NZ) Limited
Manufacturer: Medreich Limited, Bangalore, India
Product: Yaz Plus
Active tablet:
Active Ingredients: Drospirenone 3mg
Ethinylestradiol betadex clathrate 0.02mg
Levomefolate calcium 0.451mg
Dosage Form: Tablet
Placebo tablet:
Active Ingredient: Levomefolate calcium 0.451mg
Dosage Form: Tablet
New Zealand Sponsor: Bayer New Zealand Limited
Manufacturer: Schering GmbH und Co Produktions KG, Weimar, Germany
Dated this 30th day of March 2011.
MARK JACOBS, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health (pursuant to delegation given by the Minister of Health on 6 July 2001).
go2166
Next Page →
β¨ LLM interpretation of page content
π₯ Consent to the Distribution of New Medicines
π₯ Health & Social Welfare30 March 2011
Medicines Act 1981, New Medicines, Distribution
- Mark Jacobs, Acting Chief Medical Officer, Clinical Leadership, Protection and Regulation, Ministry of Health
NZ Gazette 2011, No 47